"\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0431\u0435\u0440\u0435\u0437\u043D\u0456 1996"@uk . "8622022" . . "wetenschappelijk artikel"@nl . . "scientific article published on 01 March 1996"@en . . "article scientifique publi\u00E9 en 1996"@fr . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en marzu de 1996"@ast . . "im M\u00E4rz 1996 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . "G Bertelli" . . . . "3" . . . . "764-773" . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@nl . . . "M Guelfi" . "1996-03-01T00:00:00Z"^^ . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@en . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@en . . . . . "b\u00E0i b\u00E1o khoa h\u1ECDc"@vi . . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@nl . "P Bruzzi" . . . "M Venturini" . "O Garrone" . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@nl . "14" . "R Rosso" . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@en . "M R Sertoli" . "L Del Mastro" . . "S Pastorino" . . . "10.1200/JCO.1996.14.3.764" . "Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer"@en . . . . . . .